Table 26

Key Characteristics of Studies that Strongly Influence Survival Meta-Analysis

Study omittedStarting epoetin doseBaseline Hb categoryHb target, upper limitPooled HR for death after study omitted (95% CI)
Leyland-Jones 2003 1×40,000 IU/wk12141.06(0.95; 1.18)
Henke 2003 3×300 IU/kg/wk10–12151.08(0.97; 1.21)
(none)1.11(1.00; 1.22)
Littlewood 2001 3×150 IU/kg/wk10151.16(1.04; 1.29)

From: 3, Results

Cover of Comparative Effectiveness of Epoetin and Darbepoetin for Managing Anemia in Patients Undergoing Cancer Treatment
Comparative Effectiveness of Epoetin and Darbepoetin for Managing Anemia in Patients Undergoing Cancer Treatment [Internet].
Comparative Effectiveness Reviews, No. 3.
Seidenfeld J, Piper M, Bohlius J, et al.

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.